Dr. Sachchida Nand Rai is an Assistant Professor at University Centre for Research & Development (UCRD), Chandigarh University, Punjab, India. He obtained his MSc in Biochemistry from Purvanchal University, India, and his PhD in Biochemistry from Banaras Hindu University, India. Dr. Rai researches the anti-oxidative and anti-neuroinflammatory properties of phytochemicals for the treatment of neurodegenerative diseases. He is a lifetime member of the Indian Academy of Neuroscience.

Dr. Shradha Bisht, a Professor of Pharmacology, is a distinguished researcher with a Ph.D. in Pharmacy from RUHS, Jaipur, and a Master of Pharmacy in Pharmacology from M.S. University of Baroda. Her research primarily focuses on neurodegenerative disorders, immunometabolism, and innovative drug delivery systems. Dr. Bisht has made significant contributions to the field on the therapeutics for diabetes and hepatic dysfunction and on nanotechnology-driven strategies for managing neurodegenerative disorders. She is an active member of the Association of Pharmaceutical Teachers of India and the Indian Pharmacological Society. Dr. Bisht's excellence in research was recognized with the Young Women Scientist Achievement Award in 2024 by USERC. Her scholarly work also includes authoring book chapters on neurochemical signaling in Alzheimer's disease and exploring non-pharmacological interventions. Dr. Bisht continues to advance the field with her innovative approaches and dedication to pharmacological research.

Dr. Swati Prakash, an Assistant Professor of Pharmacology, is a dedicated researcher with a Ph.D. in Pharmacology from the Indian Institute of Technology (BHU), Varanasi, and a Master's degree from Guru Ghasidas University, Bilaspur. Her research spans neurodegenerative disorders, immunometabolism, metabolic complications, and advanced drug delivery systems. Dr. Prakash has contributed significantly to the understanding of chronic inflammation and cancer, exploring key pathways and targeted therapies. Her published work on the regulation of adipose tissue inflammation and hepatic Adiponectin/AMPK levels demonstrates her expertise in addressing metabolic syndrome and fatty liver disease. Through her innovative research, Dr. Prakash is advancing the field of pharmacology, focusing on therapeutic approaches that improve health outcomes. Her academic credentials and impactful publications underscore her commitment to scientific excellence and her role as a leading researcher in pharmacological sciences.